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Effect size as the essential statistic
in developing methods for mTBI
diagnosis
Douglas Brandt Gibson*
Programs, Budget and Strategies Office, U.S. Army Research Institute, Fort Belvoir, VA, USA
The descriptive statistic known as “effect size” measures the distinguishability of two sets
of data. Distingishability is at the core of diagnosis. This article is intended to point out the
importance of effect size in the development of effective diagnostics for mild traumatic
brain injury and to point out the applicability of the effect size statistic in comparing
diagnostic efficiency across the main proposed TBI diagnostic methods: psychological,
physiological, biochemical, and radiologic. Comparing diagnostic approaches is difficult
because different researcher in different fields have different approaches to measuring
efficacy. Converting diverse measures to effect sizes, as is done in meta-analysis, is a
relatively easy way to make studies comparable.
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Mild traumatic brain injury (mTBI) is a recognized clinical entity, but surrounded by diagnostic
controversy. It can be safely stated that there is no single operational definition of what constitutes
mTBI. An operational definition in terms of a measurement method is needed in order to make the
entity of mTBI amenable to scientific investigation. Without a way to measure mTBI, it is difficult
to triage, treat, or to develop therapies for it. In this article, I hope to point out some features of
an operationalized mTBI diagnostic need to be appreciated in evaluating effectively discriminating
diagnostic methods using classical measurement theory.
The idea of an “operational” definition is that instead of positing an abstract concept and trying
to come up with a measurement method, one accepts the measurement instrument itself as the
definition of the concept. Since we struggle to come up with a definition of mTBI, it should suffice to
develop an instrument that can reliably distinguish those who have been concussed from those that
have not. The focus should be on distinguishing affected from unaffected individuals or impaired
from unimpaired, not what constitutes the abstract term “mTBI.”
The goal of an efficient diagnostic instrument development process is to maximize the discrim-
inability between an impaired population and an unimpaired (in other words, normal or control)
population, in this case, between those impaired by concussion and those who are unimpaired.
“Effect size” is a measure of this discriminability. It can be used to choose between alternative
methods of diagnosis and, in development, to gage improvements in a diagnostic method. For
comprehensive reviews of the effect size statistic, see Kelley and Preacher (1), and McGough and
Faraone (2).
Effect Size
There is more than one definition of effect size. For the sake of clarity of exposition this article
uses Cohen’s d (3). Correlation is often cited as an effect size measure but one must be clear about
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FIGURE 1 | (A) Variables involved in measuring discriminability using Cohen’s d.
m1 is the mean of one population, m2 is the mean of the other population, and s
is a measure of the dispersion of individual values around the mean, for Cohen,
the “pooled” standard deviation. (B) 1. Cohen’s small, medium, and large values
for effect size were given in the context of psychological research where,
because psychological differences measurable between people are small, large
numbers of subjects are needed to reveal them. 2. A mixture of two distributions
of the same variance must be two (2.0) SDs apart before the Gaussian curve
becomes bimodal (second derivative becomes concave down). 3. Rose’s
criterion for discriminability of signals in television requires d of 5.0. 4. If you have
a talking dog, you just need one to prove your point. Perhaps two if you insist on
a control dog.
the type of correlation being used. Methods that measure the
pair-wise association of values on different scales do not directly
correspond to themeasures of discrimination between collections
of values on a single scale that are addressed here. In short,
calculation of Cohen’s d, is independent of calculation of Pear-
son’s r. Breaking up the pairing of values drastically changes the
correlation, but the effect size as used above does not change.
Glass’s delta is interesting in that it does not used the pooled
SD as Cohen’s d does, but uses the SD of the control group. On
the one hand, a well-standardized control group might provide
very good reference values against which to test other popula-
tions. Pathological populations are generallymore variable, so this
might be a good approach. On the other hand, using the variance
of only one population distorts the picture and does not give the
empirically true difference. This is the basis of the controversy
over using p values, that is, type I errors are controlled, but type
II errors are not. Other measures, extensions of the effect size
concept, are available for multivariate use, categorical variables,
and to correct for bias. It is said that there are over one hundred
effect size measures.
Effect size measures take two factors into account, the differ-
ence between the mean values of the measures for the two groups
and the variance (roughly the spread of the data points for each
group; more exactly, the squared SD of the sample). Here is a
simple way of stating effect size:
d = (m2  m2) =s
where m1 is the mean of one population, m2 is the mean of the
other population, and s is the “pooled” SD. The effect size, d, is
often referred to as Cohen’s d (Figure 1A).
There is some debate about the SD, s, in cases where the two
populations have different SDs. One school of thought advises
using the SD of the control population (in this case, the unim-
paired population). For mTBI studies, the impaired population is
more heterogeneous than the unimpaired population because of,
for instance, differences in time elapsed since exposure and differ-
ent levels of severity. Cohen “pooled” the SDs, in effect comparing
a larger-than-measured SD for the unimpaired population and a
smaller-than-measured SD for the impaired population.
The difference between the means can be larger or smaller than
the SD. Therefore, d can vary from close to 0 to infinity.Where the
difference between the means is equal to the SD, is 1. When the
difference between the means is less than the SD, d is between 0
and 1.When the SD is less than the difference between the means,
d is>1.
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TABLE 1 | Cohen suggested that, for studies in psychology, effect sizes be
described as “small,” “medium,” or “large.”
Cohen d % Correct
Large 0.8 71
Medium 0.5 64
Small 0.2 56
The corresponding effect size values of d are given here along with the corresponding
“areas under the receiver operating characteristic (ROC) curve” or AUC, here given as “%
Correct,” or the percentage of correct determinations one would make (both true positives
and true negatives) if a test of that effect size were used to make a single decision.
Effect size is of interest in mTBI diagnosis because it allows
us to compare diagnostic measures across methodology, whether
biochemical, electrophysiological, radiological, or behavioral.
Especially of interest is that psychological measures generally
have effect sizes with d <1. Cohen in 1991 estimated that for psy-
chological tests d= 0.80 should be considered a large effect size.
Table 1 listed the d levels that Cohen considered large, medium,
and small along with the proportion of time a diagnosis based on
those effect sizes would be correct. As the table shows a diagnosis
based on a test with a large Cohen’s d would only be correct only
71% of the time.
A psychological test with an effect size as great as 1 would be
considered exceptionally high. In other fields, effect sizes as low as
1 are the exception. In communication engineering, a minimum
effect size is 5. This is the so-called “Rose criterion” (4). For
some observations, the phenomenon is so obvious and effect size
is so great that statistical tests of the distinguishability become
irrelevant. This latter type of observation is pathognomonic of
the condition.
Consider the clinician who bases an individual diagnosis of
mTBI on a test with a small effect size. Suppose the effect size is 0.2.
What percentage of such diagnoses would be correct? From the
chart above, we can see that only 56% of the clinician’s diagnoses
would be correct, hardly better than chance.
On the other hand, consider an epidemiologist who uses a small
effect size to recommend a general triage rule for triage of patients
with mTBI. If the rule were applied to 100 patients, the rule would
result in 6 fewer misdiagnoses (false negatives as well as false
positives) when compared to random assignment.
Psychological tests are often the go-to choice for mTBI diagno-
sis. But, an effect size of <1means that themistakes in diagnosis of
individuals will probably be unacceptably high. The diagnostician
will encounter both a high-false positive rate and a high-false
negative rate. Patients with the disorder will be falsely deemed
unimpaired and patients without the disorder will be falsely
deemed impaired.
TBI diagnostics fall into four broad groups: psychologi-
cal, physiological, radiological, and biochemical. Psychological
tests are generally inventories of symptoms either observed or
patient-reported. Physiological tests include tests of balance, eye-
movements, EEG, and so on. Radiological tests are based on
imaging and include such promising approaches a diffusion tensor
imaging (DTI), which can identify broken connections between
nerve cells and magnetic resonance spectroscopy (MRS), which
looks at chemical changes. Biochemical methods attempt to find
changes (generally in blood or cerebral spinal fluid), which are
correlated with trauma to the brain.
Different disciplines address different portions of the effect size
spectrum from psychology, which deals with effect sizes smaller
than d= 1.0 to engineering, which deals with effect sizes >5.0.
While the term “effect size” is used in psychology, the concept
is identical to the engineering “signal-to-noise ratio” sometimes
encountered in physiological studies. The concepts are the same
in that the difference between the means can be conceptualized as
the true “signal” and the variance (or SD or error) as the “noise.”
There does not seem to be a comparable term in biochemistry
where the less manageable terms “limit of detection” or sensitivity
are used. This choice may be due to the fact that chemical tests are
referenced to a 0 value rather than a contrasting population.
Radiology and medicine in general deal with signs and symp-
toms with such extreme effect size that they seem to have expe-
rienced no need for the concept. A broken bone, for instance, is
so obvious that detection is not an issue. This is the realm of the
“Augenblick” (blink of the eye) diagnosis.
Two Meanings of “mTBI”
It is unfortunate, but true, that in describing a measurement
method as an “mTBI diagnostic,” little distinction is made of the
immediate effects of a blow to the head versus the chronic effects.
A blow to the head produces an immediate nerve block in the
neurons of the brain. Trauma affects the ability of the axons to
conduct action potentials and results in an immediate state of
unconsciousness sometimes accompanied by motor disturbance.
With severe trauma, this transitions into coma and permanent
disability. With less severe trauma, the patient recovers conscious-
ness in a few minutes followed by a period of gradual recovery of
function. The period of immediate severe cognitive impairment is
readily observable and presents few diagnostic problems.
By contrast, the syndrome of mild cognitive impairment fol-
lowing a blow to the head is much more difficult to appreciate
behaviorally and to measure using assessment instruments. This
entity has been termed as “mild TBI” (mTBI). The source of the
impairment presumably is a loss of a proportion of the nerve
connections that were damaged in the initial insult.
Measurement of severe mental impairment in dementia has
long been done to using “mental status examinations” such as
the Folstein mini-mental state exam [MMSE; (5)]. The military
has used the MACE, the military acute assessment evaluation,
an examination that closely resembles the MMSE. While mental
status examination is useful where cognitive deficits are severe,
such examinations lack the power to distinguish mild cognitive
deficits.
The ability of the MACE to distinguish impaired versus unim-
paired cognitive ability drops off rapidly. On the day of injury
McCrea’s work (6) suggests a d of 1.17 in a sports concussion
setting. Kennedy’s study (7) of soldiers examined <6 h after injury
suggests a d of 1.12; by contrast, those examined between 6 and
12 h after injury had d of 0.53 (8). Coldren et al. (9) looked at sol-
diers in combat operations more than 12 h after injury and found
a d of 0.31. These findings are consistent with a dramatic decline
in d over the space of hours. Translating this into effectiveness of
diagnosis, a drop from 80% correct diagnosis to 59%.
From the perspective of measurement theory, cognitive impair-
ment in the acute state is so great that the difference between the
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means of the impaired and unimpaired populations is so great that
it overwhelms the large variance in the behavioral measurement
instruments and produces a large effect size. Impairment in the
chronic,mTBI state, on the other hand, is too small to bemeasured
effectively with short mental status exams.
It should be noted that inability of a test distinguish a deficit is
not the same as saying no deficit exists. The existence of mild TBI
is supported by numerous examples of anecdotal evidence.
Mild traumatic brain injury varies as to both severity and time
since injury. During the acute period of victims experience, an
initial mental impairment that subsides to a point after which
it is unrecognizable to observers and unmeasurable by standard
mental status examination. Those injuredmay continue to experi-
ence subjective impairment, but objectivemeasurement of impair-
ment is needed for making decisions concerning battlefield triage,
treatment, and return to duty. The lack of objective measure-
ment hinders the gathering of epidemiological data and successful
therapeutic development efforts.
Sample Size
The relationship between effect size and sample size is interesting.
A common use of effect size is in determining the number of
subjects to use in a study in order to be satisfied that a difference,
if present, will be detected and that a difference, if detected, is
real. Power analysis is the technique that is used for establish-
ing the number of subjects that will be required given a known
or estimated effect size. To distinguish small effect sizes large
numbers of subjects are recommended. Large effect sizes, on the
other hand, are easily discriminated. The relationship between
effect size and the number of subjects needed is illustrated below
(Figure 1B).
Improving the Diagnostic
One of the advantages of conceptualizing diagnostics in terms of
classical measurement theory is that it leads naturally to a rational
method toward the goal of maximizing the effect size. Classical
theory is based on the conception that the measured value has
two additive components, a “true” value, plus or minus some
“error” value. By repeatedly measuring, the mean and the SD can
be estimated. The mean is the best estimate of the true value; the
SD is the best estimate of the overall error.
If the difference between the two means is the true measure
of the difference between the impaired and unimpaired groups,
improvements in the measurement method will not substantially
change that difference, hence not changed the effect size. Reduc-
ing the error in the measurement, however, will improve the
ability of the measurement error to distinguish between the two
populations.
Steps to improve the diagnostic can be easily quantified. Vari-
ances (squared SDs) can be added and subtracted. Components
of the overall error can be identified by measuring them and
assessing their overall contribution to the error using analysis of
variance or regression techniques.
In the process of test development, the validation of the instru-
ment is expensive and time consuming. But, since the effect size
depends on both the variance of the unimpaired (normal or
control) population, much developmental work can be done using
readily available subjects without seeking out the more elusive
concussed subjects. An axiom of classical measurement theory
is that a test cannot be valid if it is not reliable. Much can be
done to increase effect size by increasing the reliability of the test
prior to engaging in validity studies. One source of unreliability
that can be addressed early is inconsistency in administration of
the instrument. Another way to increase reliability is to increase
the number of measurements. Psychologists have long used the
Spearman–Brown formula (10, 11) to estimate the increase in
reliability that can be gained by adding items to a test battery.
The same logic can be applied to other measurement methods.
Some physiological instruments such as eye tracking devices and
electroencephalographic techniques lend themselves readily to
acquiring multiple measurements.
Because variance (but not SDs) can be added and subtracted,
in the situation in which the unimpaired population (A) is less
heterogeneous than the impaired population (B) the variance of
B minus A gives the variance due to impairment. This variance,
as noted above, may be due to differences in time elapsed since
exposure and/or different levels of severity. One way to increase
effect size then would be to select subjects for the impaired
population who were more identical in these features. Errors in
subject selection can definitely increase variance and reduce effect
size by blurring the distinction between controls and affected
individuals. Impaired individuals, perhaps from head trauma long
ago, if included in the control group increases variance in one
of the groups being compared. An individual who may have had
a head injury, but were unaffected, if included in the impaired
group, affect variance on the other side. Clearly, for extreme
care must be exercised in subject selection. A good strategy
might be to start with extreme examples and work toward subject
groups more representative of the population as a whole. For a
review addressing recruitment of narrowly defined populations,
see Sadler et al. (12).
Discussion and Summary
The development of effective diagnostics for mTBI need not have,
as a pre-requisite, a rationally developed definition. Instead, an
empirically developed “operational” definition should be the aim.
For example, in practice, clinicians do not refer to an abstract
definition of diabetes, but rather use test results, blood glucose,
A1C levels as the operationalized definition of the disorder.
The practical meaning of small and large effect sizes has been
described. Some landmarks along the spectrum of effect size
are provided. Different researchers who are involved with mTBI
research address different portions of that continuum: epidemiol-
ogists, psychologists and psychiatrists, physiologists, biochemists,
physicians (including radiologists), and engineers. Different spe-
cialties may use different terms for the concept of effect sixe. For
example, there is an equivalence between the psychologist’s effect
size and the engineer’s signal-to-noise ratio. One of the objects of
this paper has been to furnish useful context for appreciating the
meaning of effect size.
Two arenas are discussed in which and understanding of effect
size can be useful: in comparing diagnostics on the same scale
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for choosing potential diagnostic approaches for funding and
for developing the discriminability of diagnostics by a focus on
their reliability (low variance). The effect size statistic allows
comparison of the effectiveness of different diagnostic methods
no matter how diverse or different they are. For the investigator
trying to improve on a given method, the paramount need for
reducing variance becomes obvious. Effect size, the central mea-
sure guiding diagnostic development, is a statistic that normalizes
mean differences over variance. And, the utility of approaching
diagnostic development from the standpoint of reducing variance
was discussed.
Two very distinct phases follow a concussive event. These need
to be considered separately in diagnosis: the immediate high-
effect size, acute impairment following head trauma, and the low-
effect size chronic after effects. The acute symptoms are obvious
enough to be assessed using almost any instrument and resemble
the decline in abilities measured by general mental status testing.
The effect size approach outlined can be used in all of the four
mainmethods proposed formTBI diagnosis. The concept of effect
size is well established in psychology and, in another form, in
engineering. In biochemical and radiological studies, it is perhaps
not as widely used as it should be.
Several related issues have not been discussed in order to
highlight the meaning of the effect size statistic (13). There is
a long-standing debate over the extent to which chronic mTBI
symptoms following combat head trauma overlap with symptoms
caused by combat stress, the symptom cluster known as post-
traumatic stress disorder. That debate is not addressed here. The
weighting of the cost of the two kinds of mistakes, false negatives
and false positives, is an important issue that begs attention,
but it is independent of the concerns surrounding development
of an objective diagnostic measurement instrument. Likewise, a
concern aboutmTBI as a relatively rare disorder and the effect that
has on the number of false positives has been omitted. Subtleties of
themathematics of the concept of effect size have beenminimized
here in order to emphasize the practical conceptual meaning of
the statistic. The issue of extending the two-group comparison dis-
cussed here tomultiple disorders and usingmultiplemeasurement
methods has not been included.
An outline of a classicalmeasurement approach to development
of an empirical, operational diagnostic has been described. For
such development, the essence of a good diagnostic is its ability to
distinguish impaired from unimpaired individuals. The measure
of discriminability is the statistic effect size.
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